Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: Effect of silica architecture on immunological properties

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 351-358

  Wang, Tianyi ^a   Jiang, Haitao ^a   Zhao, Qinfu ^a   Wang, Siling ^a   Zou, Meijuan ^a   Cheng, Gang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Oral vaccine adjuvant; Porous silica nanoparticles; Silica architecture

Indexed keywords

BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; NANOPARTICLE; NITROGEN; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCANNING ELECTRON MICROSCOPY; TH1 CELL; TH2 CELL; TRANSMISSION ELECTRON MICROSCOPY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADSORPTION; ANIMALS; ANTIGENS; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL SECRETIONS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MUCOUS MEMBRANE; NANOPARTICLES; NITROGEN; SALIVA; SERUM ALBUMIN, BOVINE; SILICON DIOXIDE; VACCINES;

EID: 84865304241     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.028     Document Type: Article

References (29)

1. E. Balasse, J. Odot, G. Gatouillat, M.C. Andry, and C. Madoulet Enhanced immune response induced by BSA loaded in hydroxyethyl-starch microparticles Int. J. Pharm. 353 2008 131 138
2. R. Bomford, M. Stapleton, S. Winsor, A. McKnight, and T. Andronova The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants AIDS Res. Hum. Retroviruses 8 1992 1765 1771
3. D.J. Brayden, and A.W. Baird Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery Adv. Drug Deliv. Rev. 56 2004 721 726
4. L.V. Carvalho, R.C. Ruiz, K. Scaramuzzi, E.B. Marengo, J.R. Matos, and D.V. Tambourgi Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15 Vaccine 28 2010 7829 7836
5. E.E. Comoy, A. Capron, and G. Thyphronitis In vivo induction of type 1 and 2 immune responses against protein antigens Int. Immunol. 9 1997 523 531
6. J.C. Cox, and A.R. Coulter Adjuvants-a classification and review of their mode of action Vaccine 15 1997 248 256
7. A. Des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Préat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 2006 1 27
8. A. Des Rieux, E.G.E. Ragnarsson, E. Gullberg, V. Preat, Y.J. Schneider, and P. Artursson Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium Eur. J. Pharm. Sci. 25 2005 455 465
9. X. Du, and J. He Fine-tuning of silica nanosphere structure by simple regulation of the volume ratio of cosolvents Langmuir 26 2010 10057 10062
10. H. Grewal, T. Hemming Karlsen, H. Vetvik, C. Ahren, K. Hakon, and B. Haneberg Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses J. Immunol. Methods 239 2000 53 62
11. H. Jakobsen, and I. Jonsdottir Mucosal vaccination against encapsulated respiratory bacteria-new potentials for conjugate vaccines Scand. J. Immunol. 58 2003 119 128
12. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 1990 821 826
13. A. Katiyar, S. Yadav, P.G. Smirniotis, and N.G. Pinto Synthesis of ordered large pore SBA-15 spherical particles for adsorption of biomolecules J. Chromatogr. A 1122 2006 13 20
14. J. Kunisawa, Y. Kurashima, and H. Kiyono Gut-associated lymphoid tissues for the developpent of oral vaccines Adv. Drug Deliv. Rev. 2011 10.1016/j.addr.2011.07.003
15. I.K. Kwon, S.H. Jeong, E. Kang, and K. Park Nanoparticulate drug delivery systems for cancer therapy Cancer Nanotechnol. 2007 333 344
16. E.C. Lavelle, S. Sharif, N.W. Thomas, J. Holland, and S.S. Davis The importance of gastrointestinal uptake of particles in the design of oral delivery systems Adv. Drug Deliv. Rev. 18 1995 5 22
17. Z. Li, L. Zhang, W. Sun, Q. Ding, Y. Hou, and Y. Xu Archaeosomes with encapsulated antigens for oral vaccine delivery Vaccine 29 2011 5260 5266
18. S. Lofthouse Immunological aspects of controlled antigen delivery Adv. Drug Deliver. Rev. 54 2002 863 870
19. J. Mestecky, Z. Moldoveanu, S.M. Michalek, C.D. Morrow, R.W. Compans, and D.P. Schafer Current opinions for vaccine delivery systems by mucosal routes J. Control. Release 48 1997 243 257
20. S. Minato, K. Iwanaga, M. Kakemi, S. Yamashita, and N. Oku Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity J. Control. Release 89 2003 189 197
21. D.T. O'Hagan Intestinal translocation of particulates-implications for drug and antigen delivery Adv. Drug Deliv. Rev. 5 1990 265 285
22. G.B. Patel, H. Zhou, A. Ponce, and W. Chen Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines Vaccine 25 2007 8622 8636
23. I.I. Slowing, J.L. Vivero-Escoto, C.W. Wu, and V.S.Y. Lin Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Deliv. Rev. 60 2008 1278 1288
24. W. Xu, Q. Gao, Y. Xu, D. Wu, Y. Sun, W. Shen, and F. Deng Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres Powder Technol. 191 2009 13 20
25. Y. Zhang, J. Zhang, T. Jiang, and S. Wang Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties Int. J. Pharm. 410 2011 118 124
26. Y. Zhang, Z. Zhi, T. Jiang, J. Zhang, Z. Wang, and S. Wang Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan J. Control. Release 145 2010 257 263
27. D.Y. Zhao, J.L. Feng, Q.S. Huo, N. Melosh, G.H. Fredrickson, B.F. Chmelka, and G.D. Stucky Triblock copolymer syntheses ofmesoporous silica with periodic 50-300 angstrom pores Science 279 1998 548 552
28. R.M. Zinkernagel Localization dose and time of antigens determine immune reactivity Sem. Immunol. 12 2000 163 171
29. R.M. Zinkernagel, S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner Antigen localization regulates immune responses in a dose and time dependent fashion: a geographical view of early immunity Immunol. Rev. 156 1997 199 209